Anti-apoptotic Activity of Human Matrix Metalloproteinase-2 Attenuates Diabetes Mellitus

• Material Type: 博士論文
• Title: Anti-apoptotic Activity of Human Matrix Metalloproteinase-2 Attenuates Diabetes Mellitus
• Author/Editor: Nishihama, Kota
• Author Heading: Nishihama, Kota
• Publication, Distribution, etc.: 三重大学
• Publication Date: 2018-03-26
• Publication Date (W3CDTF): 2018-03-26
• Alternative Title: ヒトマトリックスメタロプロテイナーゼ2の抗アポトーシス作用は糖尿病に保護的に働く
• Degree grantor/type: 三重大学
• Date Granted: 2018-03-26
• Date Granted (W3CDTF): 2018-03-26
• Dissertation Number: 甲医学第1883号
• Degree Type: 博士(医学)
• Conferring No. (Dissertation): 甲医学第1883号
• Text Language Code: eng
• Alias of Author: ニシハマ, コウタ; 西濵, 康太
• Subject Heading: Akt signaling pathway; Apoptosis; Diabetes; Integrins; Islet β-cell; Metalloproteinases
• Target Audience: 一般
• Note (General): application/pdf; BACKGROUND: Chronic progression of diabetes is associated with decreased pancreatic islet mass due to apoptosis of β-cells. Patients with diabetes have increased circulating matrix metalloproteinase-2 (MMP2); however, the physiological significance has remained elusive. This study tested the hypothesis that MMP2 inhibits cell apoptosis, including islet β-cells.METHODS: Samples from diabetic patients and newly developed transgenic mice overexpressing human MMP2 (hMMP2) were harnessed, and diabetes was induced with streptozotocin.RESULTS: Circulating hMMP2 was significantly increased in diabetic patients compared to controls and significantly correlated with the serum C-peptide levels. The diabetic hMMP2 transgenic mice showed significant improvements in glycemia, glucose tolerance and insulin secretion compared to diabetic wild type mice. Importantly, the increased hMMP2 levels in mice correlated with significant reduction in islet β-cell apoptosis compared to wild-type counterparts, and an inhibitor of hMMP2 reversed this mitigating activity against diabetes. The increased activation of Akt and BAD induced by hMMP2 in β-cells compared to controls, links this signaling pathway to the anti-apoptotic activity of hMMP2, a property that was reversible by both an hMMP2 inhibitor and antibody against integrin-β3.CONCLUSION: Overall, this study demonstrates that increased expression of hMMP2 may attenuate the severity of diabetes by protecting islet β-cells from apoptosis through an integrin-mediated activation of the Akt/BAD pathway.; 本文 / Department of Diabetes, Metabolism and Endocrinology, Mie University Graduate School of Medicine; 46p
• DOI: info:doi/10.1016/j.metabol.2018.01.016; https://doi.org/info:doi/10.1016/j.metabol.2018.01.016
• Persistent ID (NDL): info:ndljp/pid/11123707; https://dl.ndl.go.jp/pid/11123707
• Collection: 障害者向け資料
• Collection (Materials For Handicapped People:1): テキストデータ
• Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文; https://dl.ndl.go.jp/collections/A00014
• Acquisition Basis: 博士論文（自動収集）
• Date Accepted (W3CDTF): 2018-08-03T23:36:01+09:00
• Date Created (W3CDTF): 2018-07-19
• Format (IMT): application/pdf
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
• Availability of remote photoduplication service: 可
• Periodical Title (URI): http://hdl.handle.net/10076/00017693; https://mie-u.repo.nii.ac.jp/records/12060
• Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp

Table of Contents

2023-12-15 再収集